Updated Jul 16, 2026
Bowden Christopher has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Bowden Christopher is listed as a Director of Bicara Therapeutics Inc. in SEC filings as of 2026-06-10. Public disclosures accompanying the filing provide limited biographical information beyond the individual's role; no further background details are publicly documented in the provided SEC context.
| Role | Director |
|---|---|
| Notability | 35/100 |
Bowden Christopher is listed as a Director of Bicara Therapeutics Inc. in SEC filings as of 2026-06-10. Public disclosures accompanying the filing provide limited biographical information beyond the individual's role; no further background details are publicly documented in the provided SEC context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bowden Christopher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.